Search results
Results From The WOW.Com Content Network
Pseudothrombocytopenia (PTCP) or spurious thrombocytopenia is an in-vitro sampling problem which may mislead the diagnosis towards the more critical condition of thrombocytopenia. The phenomenon may occur when the anticoagulant used while testing the blood sample causes clumping of platelets which mimics a low platelet count. [ 1]
Treatment. None, immunosuppressants, platelet transfusion, surgical removal of the spleen [ 1] In hematology, thrombocytopenia is a condition characterized by abnormally low levels of platelets (also known as thrombocytes) in the blood. [ 2] Low levels of platelets in turn may lead to prolonged or excessive bleeding.
Thrombocythemia. In hematology, thrombocythemia is a condition of high platelet (thrombocyte) count in the blood. Normal count is in the range of 150 × 10 9 to 450 × 10 9 platelets per liter of blood, [1] but investigation is typically only considered if the upper limit exceeds 750 × 10 9 /L. When the cause is unknown, the term ...
Kasabach–Merritt syndrome ( KMS ), also known as hemangioma with thrombocytopenia, [ 1] is a rare disease, usually of infants, in which a vascular tumor leads to decreased platelet counts and sometimes other bleeding problems, [ 2] which can be life-threatening. [ 3] It is also known as hemangioma thrombocytopenia syndrome.
Thrombocytopenia with absent radius syndrome. Specialty. Medical genetics. TAR syndrome ( thrombocytopenia with absent radius) is a rare genetic disorder that is characterized by the absence of the radius bone in the forearm and a dramatically reduced platelet count. [1] It is associated with cardiac defects, dysmorphic features, and petechiae.
Less than 100 cases have been reported. [ 3] Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive bone marrow failure syndrome characterized by severe thrombocytopenia, which can progress to aplastic anemia and leukemia. [ 4] CAMT usually manifests as thrombocytopenia in the initial month of life or in the fetal phase.
Neonatal alloimmune thrombocytopenia (NAITP, NAIT, NATP or NAT) is a disease that affects babies in which the platelet count is decreased because the mother's immune system attacks her fetus' or newborn's platelets. A low platelet count increases the risk of bleeding in the fetus and newborn.
In a 2005 article, Weinstein wrote that the unexplained postpartum death of a woman who had haemolysis, abnormal liver function, thrombocytopenia, and hypoglycemia motivated him to review the medical literature and to compile information on similar women. [10] He noted that cases with features of HELLP had been reported as early as 1954. [10] [52]